Latest Cystic fibrosis Stories
As part of a limited panel, the nation's largest independent specialty pharmacy will offer PARI's cystic fibrosis treatment, a 28-day supply of Tobramycin Inhalation Solution together with a PARI LC
DALLAS, March 12, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Cystic Fibrosis - Pipeline Review, H1 2015" therapeutic market research report provides an overview of
SOUTH PLAINFIELD, N.J., March 3, 2015 /PRNewswire/ -- PTC Therapeutics, Inc.
It’s that time of year again when CEO and Owner of FiltersFast.com, Ray Scardigno, will once again participate in the Charlotte, NC Chapter’s Xtreme Hike, on April 18, 2015.
BOULDER, Colo., Feb.
Trial also demonstrates strong trends in secondary clinical endpoints AUSTIN, Texas, Feb.
New medical director named to lead the growth of Dayton Children's Cystic Fibrosis Center, where research trials are making breakthroughs in finding new therapies and treatments and helping
SARATOGA, Calif., Feb.
RICHMOND, Va., Feb. 11, 2015 /PRNewswire/ -- The first patient has been enrolled in the PARI PROVIDE compressor access program to accompany the launch of Kitabis Pak.
Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...
- Emitting flashes of light; glittering.